Baird Adjusts Medpace Holdings' Price Target to $469 From $456, Keeps Outperform Rating
Medpace Hldgs Analyst Ratings
Medpace Hldgs Analyst Ratings
Medpace Holdings (MEDP) Receives a New Rating From TD Cowen
Medpace Hldgs Analyst Ratings
Medpace Holdings (MEDP): A Strong Buy on Robust Organic Growth and Financial Stability
Medpace Hldgs Analyst Ratings
Medpace Hldgs Analyst Ratings
Medpace Hldgs Analyst Ratings
Medpace Hldgs Analyst Ratings
Medpace Hldgs Analyst Ratings
Medpace Hldgs Analyst Ratings
UBS Adjusts Medpace Price Target to $282 From $270, Maintains Neutral Rating
Medpace Holdings (NASDAQ:MEDP) Explodes Upward After Earnings, Analyst Weigh-In
Baird Upgrades Medpace Hldgs to Outperform, Raises Price Target to $289
Medpace Hldgs Analyst Ratings
Analysts Conflicted on These Healthcare Names: Medpace Holdings (MEDP) and Silk Road Medical (SILK)
UBS Adjusts Medpace Price Target to $270 From $215, Maintains Neutral Rating
Guggenheim Raises Medpace Holdings' Price Target to $273 From $252, Keeps Buy Rating
Guggenheim Maintains Buy on Medpace Hldgs, Raises Price Target to $273